Invitrogen Nails Down $2.5B in Financing for ABI Deal

genomeweb
360dx

Invitrogen Nails Down $2.5B in Financing for ABI Deal

Sep 26, 2008

NEW YORK (GenomeWeb News) – Invitrogen said today that it has secured the financing lines it will need to complete its acquisition of Applied Biosystems, a deal valued at around $6.7 billion in cash and stock.

To read the full story....

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

Roche to Close NimbleGen Site, Lay Off 79 by Mid-2020
New Products Posted to GenomeWeb: Thermo Fisher Scientific, Twist Bioscience, 10X Genomics, More
LexaGene Announces C$5M Bought Deal Financing
Large Study Uncovers Genetic Connections Between Numerous Psychiatric Disorders
Cigna to Cover GenomeDx's Decipher Prostate Cancer Tests
Nightingale, UK Biobank to Analyze Metabolomic Markers in 500K Blood Samples

The Scan

Privacy Policy Information, Please

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

Moving the Parts About

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

This Week in Science

In Science this week: genetic overlap among many psychiatric disorders, and more.

Just Skip that Step

The Economist writes that an increasing number of scientific journals don't do peer review.

Main menu